Follow
Carlos Castellanos
Carlos Castellanos
Co-Founder Bioforce Medical Inc.
Verified email at cornell.edu
Title
Cited by
Cited by
Year
Surfactant functionalization induces robust, differential adhesion of tumor cells and blood cells to charged nanotube-coated biomaterials under flow
MJ Mitchell, CA Castellanos, MR King
Biomaterials 56, 179-186, 2015
582015
Nanostructured surfaces to target and kill circulating tumor cells while repelling leukocytes
MJ Mitchell, CA Castellanos, MR King
Journal of Nanomaterials 2012, 5-5, 2012
372012
Immobilized surfactant‐nanotube complexes support selectin‐mediated capture of viable circulating tumor cells in the absence of capture antibodies
MJ Mitchell, CA Castellanos, MR King
Journal of Biomedical Materials Research Part A 103 (10), 3407-3418, 2015
322015
Differentially charged nanomaterials control selectin-mediated adhesion and isolation of cancer cells and leukocytes under flow
MJ Mitchell, CA Castellanos, MR King
2014 40th Annual Northeast Bioengineering Conference (NEBEC), 1-2, 2014
12014
Isolation of Circulating Tumor Cells Using Electric Fields
CA Castellanos, MA Holgate
US Patent App. 15/963,329, 2018
2018
Exploiting serum interactions with cationic biomaterials enables label-free circulating tumor cell isolation
C Castellanos
Cornell University, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–6